Phenotypic and Functional Outcome of Human Monocytes or Monocyte-Derived Dendritic Cells in a Dermal Equivalent

This publication has 27 references indexed in Scilit:

• Characterization of E-Cadherin-Containing Junctions Involving Skin-Derived Dendritic Cells
  Journal of Investigative Dermatology, 1999
• Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans Cells
  The Journal of Experimental Medicine, 1998
• Macrophages, but Not Langerhans Cell-like Cells of Dendritic Lineage, Express the CD36 Molecule in Normal Human Dermis: Relevance to Downregulatory Cutaneous Immune Responses?
  Journal of Investigative Dermatology, 1996
• Distinction of Class II MHC+ Langerhans Cell-Like Interstitial Dendritic Antigen-Presenting Cells in Murine Dermis from Dermal Macrophages
  Journal of Investigative Dermatology, 1994
• Proliferating dendritic cell progenitors in human blood.
  The Journal of Experimental Medicine, 1994
• Antigen-presenting capacity in normal human dermis is mainly, subserved by CDla+ cells
  British Journal of Dermatology, 1994
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991
• Cutaneous Dermal Ia+ Cells Are Capable of Initiating Delayed Type Hypersensitivity Responses
  Journal of Investigative Dermatology, 1990
• Antigen-Presenting Cells in the Induction of Contact Hypersensitivity in Mice: Evidence that Langerhans Cells Are Sufficient but not Required
  Journal of Investigative Dermatology, 1989